Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: Case report and review

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 1, 1999, Pages 53-57

  Waldron, Peter E ^a,c   Rodgers, Bradley M ^a   Kelly, Maria D ^a   Womer, Richard B ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Chemotherapy; Dose intensification; Radiation therapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER STAGING; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DOSE KIDNEY FUNCTION RELATION; GASTRECTOMY; HUMAN; KIDNEY CANCER; LABORATORY TEST; MALE; PRIORITY JOURNAL; REMISSION; RHABDOID TUMOR; SURVIVAL RATE;

EID: 0033062366     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199901000-00012     Document Type: Article

References (28)

1. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of the kidney: A report of 111 cases from the National Wilms Tumor Study Pathology Center. AmJSurg Pathol 1989;13:439-58.
2. Liu Y, Li P, Liu S. Malignant rhabdoid tumor of kidney: a clinicopathologic and immunohistochemical study of 15 patients. ChungHua Ping Li Hsueh Tsa Chih - Chinese J of Pathol 1995;24:72-4.
3. Vujanic GM, Sandstedt B, Harms D, et al. Rhabdoid tumor of the kidney: A clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file. Histopathol 1996;28:333-40.
4. Schmidt D, Leuschner I. Harms D, et al. Malignant rhabdoid tumor: A morphological and flow cytometric study. Pathol Res Pract 1989;184:202-10.
5. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms tumor: Results of the Third National Wilms Tumor Study. Cancer 1989;64:349-60.
6. Gururangan S, Bowman LC, Parham DM, et al. Primary extracranial rhabdoid tumors. Cancer 1993;71:2653-9.
7. Palmer NF, Sutow W. Clinical aspects of the rhabdoid tumor of the kidney: A report of the National Wilms Tumor Study Group. Med Pediatr Oncol 1983;11:242-5.
8. Shashi V, Lovell MA, von Kap-herr C, et al. Malignant rhabdoid tumor of the kidney: Involvement of chromosome 22. Genes Chromosomes Cancer 1994;10:49-54.
9. Womer RB, Daller RT, Miser A, et al. G-CSF allows dose intensification by interval reduction in pediatric sarcomas. Proc Am Soc Clin Oncol 1993;12:138.
10. Bonnin JM, Rubinstein LJ, Palmer NF, et al. The association of embryonal tumors originating in the kidney and in the brain. Cancer 1984; 54:2137-46.
11. Green DM, Fernbach DJ, Norkool P, et al. The treatment of Wilms tumor patients with pulmonary metastases detected only with computed tomography: A report from the National Wilms Tumor Study. J Clin Oncol 1991;9:1776-81.
12. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms tumor: Results of the National Wilms Tumor Study. Cancer 1976;38:633-46.
13. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms tumor: Results of the second National Wilms Tumor Study. Cancer 1981;47:2302-11.
14. Corey SJ, Andersen JW, Vawter GF, et al. Improved survival for children with anaplastic Wilms tumors. Cancer 1991;68:970-4.
15. Hirose M, Yamada T, Toyosaka A, et al. Rhabdoid tumor of the kidney: A report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13). Med Pediatr Oncol 1996;27:174-8.
16. Weeks DA, Beckwith JB, Mierau GW. Rhabdoid tumor: An entity oraphenotype? Arch Pathol Lab Med 1989;113:113-4.
17. Haas JE, Palmer NF, Weinberg AG, et al. Ultrastructure of malignant rhabdoid tumor of the kidney: A distinctive renal tumor of children. Hum Pathol 1981;12:646-57.
18. Sotelo-Avila C, Gonzalez-Crussi F, deMello D, et al. Renal and extrarenal rhabdoid tumors in children: A clinicopathologic study of 14 patients. Semin Diagn Pathol 1986; 3:151-63.
19. Sen S, Kadamba P. Al-AbdulAaly M, et al. Results of Wilms tumour management in two tertiary-care hospitals in Asia. Pediatr Surg Int 1998;13:42-4.
20. Flentje M, Weirich A. Graf N, et al. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Int J Radiat Oncol Biol Phys. 1998;40:163-9.
21. Tomlinson GE, Breslow NE, Moksness J, et al. Prognostic factors in rhabdoid tumor of the kidney: Results of the National Wilms Tumor Study Group. Proc Am Soc Clin Oncol 1996;15: A1444.
22. Freiman JA, Chalmers TC, Smith H Jr, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
23. Woll PJ, Hodgetts J, Lomax L, et al. Thatcher N. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol 1995;13:652-9.
24. O'Reilly SM, Smith DB, Newlands ES, et al. Dose intensification in the treatment of patients with testicular germ cell tumours. Eur J Cancer 1994;30A:723.
25. Seidman AD, Scher HI, Gabrilove JL, et al. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer. J Clin Oncol 1993;11:408-14.
26. Neidhart JA. Dose intense treatment of breast cancer supported with GM-CSF. Breast Cancer Res Treat 1991;20(Suppl):15-20.
27. Kushner BH, Meyers PA, Gerald WL, et al. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing sarcoma, in children and young adults. J Clin Oncol 1995;13:2796-04.
28. Lukens JN. Progress resulting from clinical trials: Solid tumors in childhood cancer. Cancer 1994;74(9 Suppl):2710-8.